NCDC Laboratory Evaluation
According to NCDC documents dated 4 September 2026, the ready-to-use MOLISAN solution demonstrated full effectiveness after 15 minutes of exposure for antiseptic preparation of surgical and injection areas of the skin.
The laboratory report for MOLISAN sample 26CO414840 records No Growth for P. aeruginosa ATCC 27853, E. hirae ATCC 10541 and S. aureus ATCC 25923.
Laboratory setting: BSL-2
Official NCDC Letter
Formal conclusion / official communication
Laboratory Test Results
Underlying laboratory record supporting the letter
Archive document
Laboratory report №310-52-240
Date: 30.10.2014
Laboratory test of MOLISAN solution dated 30 October 2014. The report records physicochemical parameters; lead, arsenic and mercury were not detected.
Archive document
Declaration of conformity №01
Date: 30.10.2014 · Validity period: 30.10.2014 — 30.10.2015
Declaration of conformity for liquid MOLISAN, based on testing performed in 2014. The document card lists its validity period.
Archive document
Quality certificate GLOBALTEST №319
Date: 01.07.2015 · Validity period: 01.07.2015 — 07.2016
GLOBALTEST certificate No. 319 for MOLISAN antiseptic solution, specification No. 01-0615. The document records the product’s physicochemical parameters.
Archive document
General toxicity study — MOLISAN
Date: 2015
General-toxicity study of MOLISAN, Tbilisi State Medical University, 2015. The studied composition lists distilled water, sodium chloride and tea tree, eucalyptus and peppermint essential oils.
The 2015 preclinical study of MOLISAN found no acute toxic, cumulative, locally irritating or allergic effects of the tested preparation in laboratory animals.
Archive document
Quality certificate GLOBALTEST №76
Date: 09.03.2016 · Validity period: 09.03.2016 — 16.08.2017
GLOBALTEST certificate No. 76 for MOLISAN ELIXIR, specification No. 02-0216. Issued on 9 March 2016.
Archive document
General toxicity study — MOLISAN ELIXIR
Date: 2016
General-toxicity study of MOLISAN ELIXIR, Tbilisi State Medical University, 2016. The studied composition lists demineralized water, sodium chloride and tea tree, manuka, lemon, kanuka, eucalyptus, basil, orange, fennel and peppermint essential oils.
The 2016 preclinical study of MOLISAN ELIXIR found no acute toxic, cumulative, locally irritating or allergic effects of the tested preparation in laboratory animals.
Archive document
Quality certificate GLOBALTEST №81
Date: 09.03.2016 · Validity period: 09.03.2016 — 25.08.2017
GLOBALTEST certificate No. 81 for MOLISAN LOTION, specification No. 03-0316. Issued on 9 March 2016.
Archive document
General toxicity study — MOLISAN LOTION
Date: 2016
General-toxicity study of MOLISAN LOTION, Tbilisi State Medical University, 2016. The studied composition lists demineralized water, salt, gold and essential oils.
The 2016 preclinical study of MOLISAN LOTION found no acute toxicity, allergenicity or local irritation from external application of the tested preparation in white mice.
Archive document
Quality certificate GLOBALTEST №528
Date: 25.11.2016 · Validity period: 25.11.2016 — 26.10.2018
GLOBALTEST certificate No. 528 for MOLISAN Rectovaginal Antiseptic, specification No. 05-1116. Issued on 25 November 2016.
Archive document
Quality certificate GLOBALTEST №527
Date: 25.11.2016 · Validity period: 25.11.2016 — 16.11.2018
GLOBALTEST certificate No. 527 for MOLISAN Bethlehem, specification No. 04-0716. Issued on 25 November 2016.
Archive document
Quality certificate GLOBALTEST №213
Date: 05.06.2017 · Validity period: 05.06.2017 — 05.2020
GLOBALTEST certificate No. 213 for Nano Gold, specification No. 06-0517. Issued on 5 June 2017.